Fortis Healthcare: Company Signs Agreement For New 400+ Bed Super Specialty Hospital In Ashok Vihar, Delhi

 16 Sep 2026 07:07 PM

Fortis Healthcare: Company Signs Agreement For New 400+ Bed Super Specialty Hospital In Ashok Vihar, Delhi

Fortis Healthcare: Co. Files Special Leave Petition Before SC Against Delhi HC Judgment Dated August 31, 2026; Case Involves Daiichi Sankyo Company And Malvinder Mohan Singh.

 16 Sep 2026 11:03 AM

Fortis Healthcare: Co. Files Special Leave Petition Before SC Against Delhi HC Judgment Dated August 31, 2026; Case Involves Daiichi Sankyo Company And Malvinder Mohan Singh.

Fortis Healthcare: To Hold Analyst And Investor Meeting On September 21 At 9 AM

 15 Sep 2026 08:32 PM

Fortis Healthcare: To Hold Analyst And Investor Meeting On September 21 At 9 AM

Fortis Healthcare: Tokyo District Court Dismisses NTK's Claim Against Daiichi Sankyo; NTK Must Cover Legal Fees and Plans to Review the Decision for Further Action.

 11 Sep 2026 12:49 PM

Fortis Healthcare: Tokyo District Court Dismisses NTK's Claim Against Daiichi Sankyo; NTK Must Cover Legal Fees and Plans to Review the Decision for Further Action.

Fortis Healthcare Limited: Ntk's Claim Against Daiichi Sankyo Dismissed By Tokyo District Court; Ntk To Bear Litigation Costs; Ntk Plans To Review Judgment And Pursue Legal Remedies.

 11 Sep 2026 12:55 PM

Fortis Healthcare Limited: Ntk's Claim Against Daiichi Sankyo Dismissed By Tokyo District Court; Ntk To Bear Litigation Costs; Ntk Plans To Review Judgment And Pursue Legal Remedies.

Fortis Healthcare: Company To Hold Analyst And Investor Meeting On September 14 And 15 At 8 AM

 09 Sep 2026 08:35 PM

Fortis Healthcare: Company To Hold Analyst And Investor Meeting On September 14 And 15 At 8 AM

Fortis Healthcare: HSBC on Fortis Healthcare Buy, Target Price ₹1,100, as the Delhi HC-ordered forensic audit is not expected to affect operations or IHH’s plan to raise its stake, with audit updates the key monitorable.

 07 Sep 2026 08:51 AM

Fortis Healthcare: HSBC on Fortis Healthcare Buy, Target Price ₹1,100, as the Delhi HC-ordered forensic audit is not expected to affect operations or IHH’s plan to raise its stake, with audit updates the key monitorable.

Fortis Healthcare: Jefferies on Fortis Healthcare Buy, Target Price ₹1,125, as the forensic audit is unlikely to disrupt operations or expansion, IHH remains committed to Fortis as its India growth platform, and any audit-led weakness is a buying opportunity given 18% FY27–29E EBITDA CAGR and attractive 24x FY28E EV/EBITDA.

 07 Sep 2026 08:51 AM

Fortis Healthcare: Jefferies on Fortis Healthcare Buy, Target Price ₹1,125, as the forensic audit is unlikely to disrupt operations or expansion, IHH remains committed to Fortis as its India growth platform, and any audit-led weakness is a buying opportunity given 18% FY27–29E EBITDA CAGR and attractive 24x FY28E EV/EBITDA.

Fortis Healthcare: Nomura on Fortis Healthcare Neutral, Target Price ₹1,030, as the forensic audit into the ₹46.7bn RHT-IHH transaction is investigative and operations/growth plans remain insulated, while IHH’s commitment to raise its stake to 51% and eventually merge Gleneagles India with Fortis broadly aligns with Street expectations.

 07 Sep 2026 08:51 AM

Fortis Healthcare: Nomura on Fortis Healthcare Neutral, Target Price ₹1,030, as the forensic audit into the ₹46.7bn RHT-IHH transaction is investigative and operations/growth plans remain insulated, while IHH’s commitment to raise its stake to 51% and eventually merge Gleneagles India with Fortis broadly aligns with Street expectations.

Fortis Healthcare: Co May Move Supreme Court Against Delhi HC Order In Daiichi Arbitration Case - Newspaper

 02 Sep 2026 09:12 AM

Fortis Healthcare: Co May Move Supreme Court Against Delhi HC Order In Daiichi Arbitration Case - Newspaper

Fortis Healthcare: Will Hold Meeting With Analysts And Investors On September 4 At 1 PM.

 01 Sep 2026 07:58 PM

Fortis Healthcare: Will Hold Meeting With Analysts And Investors On September 4 At 1 PM.

Fortis Healthcare: Forensic Audit Ordered By Delhi HC In Daiichi Case; No Liability Or Penalties Imposed

 01 Sep 2026 07:33 AM

Fortis Healthcare: Forensic Audit Ordered By Delhi HC In Daiichi Case; No Liability Or Penalties Imposed

Fortis: High Court Appoints Forensic Auditor To Investigate Fortis Religare Deal. Sankyo Requested Audit In Fortis Case.

 31 Aug 2026 10:56 AM

Fortis: High Court Appoints Forensic Auditor To Investigate Fortis Religare Deal. Sankyo Requested Audit In Fortis Case.

Fortis Healthcare: IHH Plans To Raise Its Stake In Co From 31% To 51%

 28 Aug 2026 10:09 AM

Fortis Healthcare: IHH Plans To Raise Its Stake In Co From 31% To 51%

Fortis Healthcare: Citi on Fortis Healthcare Maintains Buy with Target Price of ₹1,180 as hospital margin recovery, new bed additions, 19% hospital revenue growth and management’s 25% EBITDA margin target by FY28 support accelerating earnings growth.

 19 Aug 2026 09:08 AM

Fortis Healthcare: Citi on Fortis Healthcare Maintains Buy with Target Price of ₹1,180 as hospital margin recovery, new bed additions, 19% hospital revenue growth and management’s 25% EBITDA margin target by FY28 support accelerating earnings growth.

Fortis Healthcare: Guidance - Management maintains its consolidated EBITDA margin guidance for FY27, expecting to achieve 25% EBITDA margin by FY28, inclusive of ESOP costs, which will be offset by operational improvements.- Concall Update

 10 Aug 2026 09:05 AM

Fortis Healthcare: Guidance - Management maintains its consolidated EBITDA margin guidance for FY27, expecting to achieve 25% EBITDA margin by FY28, inclusive of ESOP costs, which will be offset by operational improvements.- Concall Update

Fortis Healthcare: Guidance - For the Diagnostic Business, management expects revenue growth of 12-13% and EBITDA margins of 24-25% for the remaining quarters of FY27, driven by continued momentum and an improved B2C mix.- Concall Update

 10 Aug 2026 09:05 AM

Fortis Healthcare: Guidance - For the Diagnostic Business, management expects revenue growth of 12-13% and EBITDA margins of 24-25% for the remaining quarters of FY27, driven by continued momentum and an improved B2C mix.- Concall Update

Fortis Healthcare: Guidance - The company plans to operationalize an additional 400 beds in the remaining three quarters of FY27, including 200 beds from the FMRI facility, and anticipates CapEx consuming approximately 50% of EBITDA for brownfield expansion and technical upgrades.- Concall Update

 10 Aug 2026 09:05 AM

Fortis Healthcare: Guidance - The company plans to operationalize an additional 400 beds in the remaining three quarters of FY27, including 200 beds from the FMRI facility, and anticipates CapEx consuming approximately 50% of EBITDA for brownfield expansion and technical upgrades.- Concall Update

Fortis Healthcare: Guidance - Key levers for margin improvement include new units (Manesar, Noida, FMRI) transitioning to positive EBITDA contribution, improved collection from government and TPAs, and increased occupancy in existing hospitals like BG Road and Mulund.- Concall Update

 10 Aug 2026 09:05 AM

Fortis Healthcare: Guidance - Key levers for margin improvement include new units (Manesar, Noida, FMRI) transitioning to positive EBITDA contribution, improved collection from government and TPAs, and increased occupancy in existing hospitals like BG Road and Mulund.- Concall Update

Fortis Healthcare: Guidance - The company is actively evaluating inorganic growth opportunities, focusing on existing clusters, and has approved a INR252 crore CapEx for a Proton facility at its Gurgaon hospital.- Concall Update

 10 Aug 2026 09:05 AM

Fortis Healthcare: Guidance - The company is actively evaluating inorganic growth opportunities, focusing on existing clusters, and has approved a INR252 crore CapEx for a Proton facility at its Gurgaon hospital.- Concall Update